Semaglutide

What is semaglutide?

Semaglutide is a synthetic GLP-1 receptor agonist and the compound that opened the current era of metabolic peptide research. It has the deepest published trial record of anything in this class, anchored by the STEP programme, and it remains the reference point against which newer agonists are measured.

It is a single-target compound. That is now its defining characteristic in comparative research, since tirzepatide and retatrutide are both defined by what they add to it.

Semaglutide research applications

Research applications centre on GLP-1 receptor signalling, appetite and satiety pathways, glucose regulation, and use as a comparator in studies evaluating dual and triple agonists. Because it came first, it also carries the longest tail of follow-up data, which matters for research questions about what happens beyond an initial study window rather than during it.

How semaglutide works

GLP-1 is an incretin hormone released after eating. It slows gastric emptying, influences insulin secretion in a glucose-dependent way, and acts on appetite signalling in the brain. Semaglutide is engineered to resist the enzymatic breakdown that clears native GLP-1 within minutes, which is what extends its activity into a usable research window.

Buy semaglutide: specifications

Semaglutide vs tirzepatide vs retatrutide

Semaglutide targets GLP-1 alone. Tirzepatide adds GIP. Retatrutide adds glucagon on top of both. Trial maturity runs in the opposite direction to mechanistic breadth: semaglutide has the most data and the narrowest mechanism, retatrutide the broadest mechanism and the least data. Which one belongs in a study design depends entirely on the question.

Our guide to peptides for weight loss for women covers the comparison in plain language.

Reconstitution and handling

Supplied lyophilized. Reconstitute with bacteriostatic water, adding the diluent slowly against the vial wall and allowing the powder to dissolve without agitation. Do not shake. Bacteriostatic water is stocked separately.

Storage and stability

Lyophilized material is stable long term at minus 20 degrees Celsius in the sealed original vial, kept away from light. Reconstituted solution needs refrigeration and a considerably shorter window. Avoid freeze and thaw cycling.

Certificate of analysis for every batch

Every batch is tested by an independent US laboratory with no ownership relationship to us, covering HPLC purity and mass spectrometry identity. Certificates are published at our research page before purchase.

Why researchers buy semaglutide from Healio

Published third-party certificates per batch, minimum 98% purity, identity confirmed rather than assumed, US dispatch, and a catalog narrow enough that we can stand behind every item in it. The rest of the metabolic range sits under peptides for weight loss.

Semaglutide FAQ

What is semaglutide used for in research?

GLP-1 receptor signalling studies, appetite and glucose regulation research, and as the standard comparator in trials evaluating newer dual and triple agonists. Supplied for laboratory use only.

Is semaglutide a peptide?

Yes, it is a synthetic peptide analog of native GLP-1, modified to resist rapid enzymatic breakdown.

How does semaglutide compare to tirzepatide?

Semaglutide targets one receptor, tirzepatide targets two. In head-to-head trial work the dual agonist performed better on the metabolic endpoints studied, though semaglutide retains the longer follow-up record.

What purity is Healio semaglutide?

Minimum 98% by HPLC with mass spectrometry identity confirmation, tested by an independent laboratory and published per batch.